Sunday, November 22, 2026
Breaking
BusinessNadula Hair Releases 2026 Black Friday Wig Trend Report BusinessWomen Leaders Association Names Sarah Oelschig First Nashville Coaching Partner BusinessUnique Rentals and Events Publishes Neighbor-First Safety Essay BusinessEgemen Mustafa Sener Integrates AI Tools Into Senerler Group's Established Construction Operations BusinessNadula Hair Releases 2026 Black Friday Wig Trend Report BusinessWomen Leaders Association Names Sarah Oelschig First Nashville Coaching Partner BusinessUnique Rentals and Events Publishes Neighbor-First Safety Essay BusinessEgemen Mustafa Sener Integrates AI Tools Into Senerler Group's Established Construction Operations
Business

Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology

Sept 25 (Reuters) - Shares in Swedish drug-delivery company Nanexa more than doubled their value in early Friday trading after it signed a global licensing deal with Novo Nordisk worth up to about €1.17 billion ($1.33 billion).

Sept 25 (Reuters) - Shares in Swedish drug-delivery company Nanexa more than doubled their value in early Friday trading after it signed a global licensing deal with Novo Nordisk worth up to about €1.17 billion ($1.33 billion). The agreement, announced after the market closed on Thursday, covers long-acting injectable drugs for obesity, type 2 diabetes and other cardiometabolic diseases. • Novo will get exclusive rights to use Nanexa's PharmaShell technology, which uses an ultra-thin coating on drug particles to control their release over time, in up to five development programmes • The companies target formulations administered monthly or quarterly, reducing the frequency of injections for chronic treatments • The deal includes an upfront payment and development and regulatory milestones totalling €615 million, with the rest coming from sales milestones • Nanexa will receive a low single-digit percentage in royalties on global sales of products developed under the agreement • Novo will lead the global development and commercialisation of products covered by the partnership • Nanexa shares are up around 122% at 0723 GMT, trading at their highest levels in more than five years ($1 = 0.8787 euros) (Reporting by Jesus Calero in Gdansk, editing by Milla Nissi-Prussak)

Source: Euronext Markets: Real-time Stock Market Data | live

Distributed to Daily · West Post by RedPress.

Related News

Contact Advertise Search RSS